Harker LA, Malpass TW, Branson HE, Hessel EA II, Slichter SJMechanism of abnormal bleeding in patients undergoing cardiopulmonary bypass: acquired transient platelet dysfunction associated with selected alpha granule release. Blood1980; 56: 823-34.
2.
Westaby S., Fleming J., Royston D.Acute lung injury during cardiopulmonary bypass, the role of neutrophil sequestration and lipid peroxidation. Trans Am Soc Artif Intern Organs1985; 31: 604-609.
3.
Shaw PJThe incidence and nature of neurological morbidity following cardiac surgery . Perfusion1989; 4: 83-91.
4.
Blauth CI, Arnold JV, Kohner EM, Taylor KMRetinal microembolism during cardiopulmonary bypass demonstrated by fluorescein angiography. Lancet1986; ii: 837-39.
5.
Colman RWPlatelet and neutrophil activation in cardiopulmonary bypass. Ann Thorac Surg1990; 49: 32-34.
6.
Marcum JA, Rosenberg RDHeparin-like molecules with anticoagulant activity are synthesized by cultured endothelial cells. Biochem Biophys Res Commun1985; 126: 365-72.
7.
Colman RW, Scott CF, Pixley RA, Cadena RAEffect of heparin on the inhibition of the contact enzymes. Annals NYAcad Sci1989; 556: 95-103.
8.
Pratt CW, Church FCAntithrombin: structure and function. Semin Hematol1991; 28: 3-9.
Grode GA, Anderson SJ, Grotta HM, Falb RDNonthrombogenic material via a simple coating process. Trans Am Soc Artif Intern Organs1969; 15: 1-5.
11.
Tanzawa H., Mori Y., Harumiya N. et al. Preparation and evaluation of a new antithrombogenic heparinized hydrophilic polymer for use in cardiovascular system. Trans Am Soc Artif Intern Organs1973; 19: 188-94.
12.
Barbucci R. , Baszkin A., Benvenutti M., de Lourdes Costa M., Ferruti P.Surface characterization of heparin-complexing poly(amido-amine) chains grafted on polyurethane and glass surfaces. J Biomed Mater Res1987; 21: 443-57.
13.
Dincer AK, Lindon JN, Salzman EWCovalent immobilization of heparin on polymethylmethacrylate surfaces. Chem Eng Commun1984; 30: 155.
14.
Goosen Mfa, Sefton MVProperties of heparin-polyvinylalcohol hydrogel coating. J Biomed Mater Res1983; 17: 359-73.
15.
Grainger DW , Kim SW, Feijen J.Polydimethylsiloxane-polyethylene oxide-heparin block copolymers I. Synthesis and characterization. J Biomed Mater Res1988; 22: 231-49.
16.
Hennink WE, Feijen J., Ebert CD, Kim SWCovalently bound conjugates of albumin and heparin: synthesis, fractionation and characterization. Thromb Res1983; 29: 1-13.
17.
Heyman PW, Cho CS, McRea JC, Olsen DB, Kim SWHeparinized polyurethanes in vitro and ex vivo studies. J Biomed Mater Res1985; 19: 419-36.
18.
Larm O., Larsson R., Olsson P.A new nonthrombogenic surface prepared by selective covalent binding of heparin via a modified reducing terminal residue. Biomat Med Dev Artif Organs1983; 11: 161-63.
19.
Toomasian JM , Zwischenberger JB, Oram AD, DeSmet GM, Bartlett RHThe use of bound heparin in prolonged extracorporeal membrane oxygenation. Trans Am Soc Artif Intern Organs1983; 30: 133-36.
20.
Reynolds L. , Clark R., Drumm G.In vitro efficacy test for arterial filter materials. Trans Soc Biomaterials1985; 115.
21.
Longmore DB , Gueierrara D., Bennett G., Smith M.Prostacyclin: a solution to some problems of extracorporeal circulation. Lancet1979 ; i: 1002-1005.
22.
Heimbecker R., Robert A., McKenzie FN. The extracorporeal pump filter - saint or sinner. Ann Thorac Surg1976; 21: 55-58.
Palanzo DA, Kurusz M., Butler BDSurface tension effects of heparin coating on arterial line filters. Perfusion1990; 5: 277-84.
25.
Hsu LC, Tong SDEvaluation of thromboresistant properties of Duraflo II heparin coated membrane oxygenator material. Trans Soc Biomaterials1990; 99.
26.
Lelah MD, Lambrecht LK, Cooper SLA canine ex vivo series shunt experiment for evaluating thrombus deposition on polymer surfaces. J Biomed Mater Res1984 ; 18: 475-96.
27.
Hsu LC, Tong SD, Patterson WRA direct method for evaluation of ECMO circuit. ASAIO Abstracts, 37th Annual Meeting, Chicago, IL, 1991: 62.
28.
Tong SD, Rolfs MR, Hsu LCEvaluation of Duraflo II heparin immobilized cardiopulmonary bypass circuits . Trans Am Soc Artif Intern Organs1990; 36: 654-56.
29.
Taylor KMDiscussion in von Segesser LK, Weiss BM, Gallino A et al. Superior hemodynamics in left heart bypass without systemic heparinization. Eur J Cardiothorac Surg1990; 4: 384-89.
30.
von Segesser LK, Turina M.Cardiopulmonary bypass without systemic heparinization . J Thorac Cardiovasc Surg1989; 98: 386-96.
31.
Toomasian JM , Hsu LC, Hirschl RB, Heiss KF, Hultquist KA, Bartlett RHEvaluation of Duraflo II heparin coating in prolonged extracorporeal membrane oxygenation. Trans Am Soc Artif Intern Organs1988; 34: 410-14.
32.
von Segesser LK, Weiss BM, Garcia E., Gallino A., Turina M.Reduced blood loss and transfusion requirements with low systemic heparinization: preliminary clinical results in coronary artery revascularization. Eur J Cardiothorac Surg1990; 4: 639-43.